logo

First Nigerian to contract Ebola discharged after full recovery

First Nigerian to contract Ebola discharged after full recovery
Nigeria’s first Ebola survivor, Ameyo Adadevoh, is a medical doctor and senior consultant in Lagos.
She was discharged from quarantine and declared fit and Ebola-free.

Ameyo is the doctor who treated Patrick Sawyer, the Liberian-American who brought Ebola into the country, on 20 July at First Consultant Hospital, and was subsequently infected with the virus herself.
Sawyer died on 25 July.

However, Ameyo has now completely recovered and has since been discharged from the Isolation centre in Lagos.

Ameyo Adadevoh, a senior consultant, was the first Nigerian infected with the virus and had been receiving treatment at the Isolation centre.

The Director of Communication and Community Mobilisation for the Nigerian Emergency Operation Centre on Ebola Virus Disease, Adebayo Onajole, confirmed to NE that Adadevoh had been discharged.

Minister of Health Onyebuchi Chukwu, who told reporters in Lagos, Nigeria’s economic hub, said the patient was discharged after conclusive discharge protocols, adding that she could go home to resume her normal life.

Five other Ebola patients have almost fully recovered, Chukwu said, ‘Nigeria had recorded 12 confirmed cases, four of which have died, while 189 people are under surveillance in Lagos, and six in southeast state of Enugu.’

According to the minister, all the persons under surveillance were secondary contacts, noting that all the patients under treatment have now moved to the new 40-bed isolated ward provided by the Lagos state government.

The minister also said the Nanosilver drug which was made available to the Emergency Operations Center in Lagos on Aug. 14, did not meet basic research requirements. Chukwu denied the rumor of Ebola virus in Imo, Abia and Cross River states while saying that the case in central-north state of Kwara was still under investigation.

Agencies

Agencies

Our Contributor help bring you the latest article around you


Exclusive

View All

Latest News

View All
Share it
Top